Introduction
============

*Streptococcus suis* type 2 (SS2), which causes septicemia, meningoencephalitis, and arthritis, is an important pathogen of pigs and humans \[[@B15]\]. Strains with high pathogenicity can even cause toxic shock syndrome in humans \[[@B10]\]. Incidence of SS2-related diseases in humans working with pigs is increasing around the world \[[@B12]\]. The bacterium enters the swine host through the respiratory tract and after colonization in the tonsils reaches the central nervous system via blood circulation, leading to fatal septicemia or meningoencephalitis \[[@B35]\]. Considerable progress has been made in recent years in deciphering the SS2 virulence factors, such as muramidase-releasing protein, suilysin, s-ribosylhomocysteinase, SalK/SsalR (a two-component system of the 89K PAI) and CovR (orphan response regulator) \[[@B4][@B10]\]. The results of such studies have led to a better understanding of the pathogenesis of SS2.

Regulation of protein function or enzyme activity by reversible phosphorylation is important for maintenance of cellular responses to dynamic internal or external environmental conditions in both prokaryotes and eukaryotes \[[@B26]\]. Serine/threonine protein phosphatases (STPs) dephosphorylate their substrate proteins in a single reaction step \[[@B24]\]. The STPs are divided into two large families, the phosphoprotein phosphatase P (PPP; PP1, PP2A, and PP2B) and the phosphoprotein phosphatase M family (PPM; PP2C), on the bases of sequence similarity, metal ion dependency, and inhibitor sensitivity \[[@B28]\]. Based on sequence similarities, *Streptococcus* (*S*.) *suis* STP belongs to the PP2C subfamily of the PPM \[[@B3]\].

Studies on prokaryotic STPs have increased in number in recent years. The STP secreted from *S. pyogenes* is apoptotic in HEp-2 cells \[[@B1]\]. *Mycoplasma genitalium* expresses STP critical for its virulence \[[@B21]\]. In *Staphylococcus aureus*, STP1 contributes to reduced virulence and susceptibility to vancomycin \[[@B7]\]. *Stp1* of group B *Streptococcus* mediates post-transcriptional regulation of hemolysin, autolysis, and virulence \[[@B24]\]. A *Streptococcus suis* serotype 9 (SS9) strain contains *stp* gene that was involved in virulence \[[@B37]\]. There are two STPs in SS2 (encoded by *stp1* and *stp2*) that belong to the PPM and PPP families, respectively \[[@B25]\]. Homology of the amino acid sequences of *stp1* between SS9 and SS2 is 99.0%, while it is 23.1% between SS9 *stp1* and SS2 *stp2*. Functions of STP in SS2 infection remain unreported to date. This study examined whether Stp1 of SS2 is a virulence factor by testing the effects of a *stp1* deletion mutant in cultured cells and mice.

Materials and Methods
=====================

Bacterial strains and culture conditions
----------------------------------------

The strains of *S. suis* and *Escherichia* (*E*.) *coli* used for cloning and mutant construction are listed in [Table 1](#T1){ref-type="table"}. The SS2 strain ZJ081101 was isolated from the lungs of a diseased pig. Brain heart infusion (BHI; Oxoid, UK) was used for culturing *S. suis* at 37℃, while Luria-Bertani broth or Luria-Bertani agar was used for culturing *E. coli*. For cloning and the selection of mutants, the following antibiotics (Sigma-Aldrich, USA) were mixed with the culture media: spectinomycin at 100 mg/mL for SS2 and 50 mg/mL for *E. coli*; chloramphenicol at 4 mg/mL for SS2 and 8 mg/mL for *E. coli*; and ampicillin at 100 mg/mL for *E. coli*.

Construction of the *stp1* mutant
---------------------------------

To construct the *stp1* deletion mutant from SS2 strain ZJ081101, the 5- and 3-flanking regions of *stp1* were PCR-amplified with primer pairs L1/L2 and R1/R2 carrying *Sph*I/*Sal*I and *Bam*HI/*Eco*RI restriction sites, respectively ([Table 2](#T2){ref-type="table"}). The *cat* gene (from pSET6s) was inserted at the *Sal*I/*Bam*HI sites to generate a gene cassette that was then transferred to the temperature-sensitive shuttle vector pSET4s after digestion by corresponding restriction enzymes to generate the *stp1*-knockout vector pSET4s-Δ*stp1* (panel A in [Fig. 1](#F1){ref-type="fig"}). Procedures for selection of mutants by allelic exchange via double crossover have been described previously \[[@B30][@B31]\]. The resulting Δ*stp1* mutant strain was verified by polymerase chain reation (PCR) amplification with primers In1/In2, Cat1/Cat2, Out1/Cat2, and Cat1/Out2 and confirmed by DNA sequencing \[[@B37]\].

Bacterial morphology by transmission electron microscope
--------------------------------------------------------

This was carried out essentially as described by Neiss et al. \[[@B22]\]. Briefly, the bacterial cells were subjected to fixation in 2.5% glutaraldehyde in phosphate buffer (pH 7.0) and treatment with 1% OsO~4~ in phosphate buffer, each followed by washing. Specimens were then dehydrated by a graded series of ethanol \[[@B29]\] from 30% to 100% and transferred to absolute acetone for 20 min. Specimens were then placed at room temperature in a mixture of absolute acetone and resin at a 1:1 ratio for 1 h, transferred to a 1:3 ratio of absolute acetone to resin mixture for 3 h, and to a Spurr\'s resin mixture for overnight. Before thin sectioning, specimens were embedded in capsules containing the embedding medium and heated at 70℃ for approximately 9 h. The bacterial sections were stained by uranyl acetate and alkaline lead citrate, each for 15 min, and inspected via transmission electron microscopy (Model H-7650; Hitachi, Japan).

Cloning, expression, and purification of recombinant *Stp1*
-----------------------------------------------------------

The ORF of *stp1* was amplified from the genome DNA of SS2 strain ZJ081101 by PCR with the primer pairs ES1-Stp1/ES2-Stp1 ([Table 2](#T2){ref-type="table"}). The verified complete gene was cloned, using the *Eco*R I and *Bgl* II sites, into pET-32a (Invitrogen, USA) which contains a 22 kDa His-tag-encoding sequence. The recombinant plasmid pET-Stp1 was transformed into *E. coli* Rosetta (DE3) for expression of the recombinant Stp1 (rStp1). *E. coli* pET-Stp1 cells in their log phase of growth were induced with 1 mmol/L of isopropyl-β-D--thiogalactopyranoside at 37℃ for 4 h. The rStp1 protein was purified by Ni^2+^-nitrilotriacetic acid affinity chromatography and concentrated by ultrafiltration (Millipore, USA). The filtrates were passed through a 0.22-µm membrane (Millipore) and held at −80℃ until use.

Phosphatase assays
------------------

p-Nitrophenyl phosphate (pNPP) was used as a substrate as described \[[@B16]\] in 500 µL of phosphatase buffer \[50 mM Tris HCl (pH 8.0), and 2 mM MnCl~2~\] containing 20 mM pNPP and 2 µg of Stp1. Hydrolysis of pNPP in the samples was measured after incubation for 10 min by determining the increase in absorbance of p-nitrophenol (pNP) at 405 nm (SpectraMax M2; Molecular Devices, USA).

Preparation of cytoplasmic and cell-wall proteins from whole bacterial lysates
------------------------------------------------------------------------------

The SS2 strains, both wild-type and mutant, were incubated at 37℃ for 6 to 7 h and used to prepare cytoplasmic and cell-wall proteins from whole bacterial cells for SDS-PAGE and western blotting. Whole bacterial lysates were prepared by treating the bacterial suspensions in a Precellys 24 homogenizer (Bertin Instruments, France) in the presence of 0.1 mm ceramic beads at 3,360 × g repeated 5 times for 30 sec each. The supernatant samples were collected as whole cell cytoplasmic proteins (CPP) after centrifugation and saved at −80℃. The precipitates were the cell-wall proteins (CWP) remaining after treatment with 1% Triton-100 in 50 mM phosphate-buffered saline (PBS).

Western blot
------------

The Bradford method was used to quantify the concentrations of the protein samples. Thirty micrograms of each protein sample were subjected to SDS-PAGE on 12% gels and transferred onto PVDF membranes (Millipore). The membranes were blocked with Tris-buffered saline containing 0.1% Tween 20 and 5% non-fat milk and subjected to probing with the antiserum to rStp1 or rGAPDH and to HRP-conjugated anti-rabbit IgG \[Multisciences (Lianke) Biotech, China\]. Chemiluminescence substrate (SuperSignal West Femto Maximum Sensitivity Substrate; Thermo Fisher Scientific, USA) was used to visualize the protein bands.

Resistance to peroxides *in vitro*
----------------------------------

The mutant strain Δ*stp1* and its parent strain were grown in BHI containing gradient concentrations of H~2~O~2~ or paraquat (a chemical generator of superoxide anions) \[[@B6]\] and incubated at 37℃. The cultures were examined at 620 nm after 4 and 8 h of incubation on SpectraMax M2 microplate reader (Molecular Devices).

*In vitro* adhesion assay
-------------------------

Adhesion of the Δ*stp1* mutant and its parent strain to murine endothelial cell line bEnd.3 and human epithelial cell line HEp-2 was determined as previously described \[[@B17]\]. Bacterial cultures at the mid-log phase (10^7^ CFU/well; CFU, colony-forming unit) were added to the cells in 24-well culture plates at 100 multiplicity of infection (MOI). The plates were spun at 800 × g for 10 min and subjected to incubation for 1 h incubation at 37℃ and 5% CO~2~. The infected cells were washed with PBS and disrupted by repeated pipetting with sterile distilled water. The cell lysates were transferred to Eppendorf tubes and vortexed to release the bacteria. The samples were then 10-fold diluted in PBS and plated on BHI agar plates for bacterial counting. Adhesion (%) was defined as (CFU~Adh~/CFU~Total~) × 100 \[[@B33]\].

Phagocytosis and intracellular survival
---------------------------------------

The murine macrophage cell line RAW264.7 was used to examine the effect of *stp1* deletion on phagocytosis and intracellular survival according to a previously reported protocol \[[@B8]\]. Briefly, the cells were incubated in RPMI 1640 medium containing 10% fetal calf serum (Gibco, USA) in 24-well plates. Wild-type and mutant SS2 strains were incubated in BHI broth for 6 h at 37℃, pelleted by centrifugation, and resuspended in sterile PBS. The cells were infected for 30 min at 37℃ at 100 MOI, washed, and incubated for 1 h in fresh RPMI 1640 medium containing gentamicin (100 mg/mL) and penicillin G (5 mg/mL) to inactivate extracellular bacteria. Cells were then washed and incubated in the fresh medium containing 20 mg/mL of gentamicin. The cells were subjected to further incubation at 37℃ and 5% CO~2~ for 1 or 2 h. After incubation, the cells were trypsinized and disrupted by repeated pipetting for bacterial enumeration on BHI agar plates. Survival (%) was calculated as CFU~2h~/CFU~1h~ × 100.

Animal infections and determination of bacterial load in organs
---------------------------------------------------------------

BALB/c mice were used in experimental infections to evaluate the role of *stp1* in SS2 virulence \[[@B36]\]. For determination of lethal dose 50 (LD~50~), eleven groups of 4-week-old female BALB/c mice (10 per group) were randomly allocated. Five groups were assigned to each strain (wild-type or its mutant Δ*stp1*), and the last group of each strain received PBS as a sham control treatment. Five gradient inoculum sizes were used for intraperitoneal infection. Mortality was recorded twice a day for 7 days post-infection. The improved Karber\'s method was used to calculate LD~50~. The bacterial burdens in blood and organs were examined in mice receiving intraperitoneal inoculation of the wild-type strain or its mutant (10 mice per strain) at 6.0--8.0 × 10^8^ CFU/mouse. Mice were euthanized at 24 and 48 h post-infection (hpi), and their brain, kidney, liver, and spleen were removed and homogenized individually in 1 mL PBS at pH 7.4. The homogenates were 10-fold diluted in PBS and appropriate dilutions were plated onto BHI agar plates. Anti-coagulant blood samples (100 µL) were collected at 24 and 48 hpi. Animal experiments were conducted following the guidelines and approved protocols of the Laboratory Animal Management Committee of Zhejiang University (approval No.2015029).

Statistical analysis
--------------------

All data are expressed as mean ± SD values of three independent experiments, each performed in triplicate in wells or tubes. The two-tailed Student\'s *t*-test was used to determine the statistical significance of differences between the *stp1* deletion mutant and its parent strain.

Results
=======

Construction of *stp1* defective mutant
---------------------------------------

A *stp1* knockout mutant was produced by electrotransforming suicide vector pSET4s containing a CatR cassette (panel A in [Fig. 1](#F1){ref-type="fig"}) into wild-type competent SS2 cells and was used to evaluate the role of *stp1* in pathogenesis. The SS2 Δ*stp1* mutant was generated by allelic change of *stp1* with *cat*, which was verified by sequencing of the PCR product. Null expression of Stp1 in the mutant was confirmed by absence of its band on the western blot probed with anti-Stp1 polyclonal antibody. The results confirmed successful inactivation of *stp1* in the SS2 strain ([Fig. 1](#F1){ref-type="fig"}).

Morphology of the mutant strain Δ*stp1* and its parent strain
-------------------------------------------------------------

The Δ*stp1* mutant had longer chains than its parent strains (panel A in [Fig. 2](#F2){ref-type="fig"}). The two strains showed difference on their surfaces as revealed by transmission electron microscope: the Δ*stp1* mutant had much fewer 'pilus-like' surface structures than its parent strain (panels B and C in [Fig. 2](#F2){ref-type="fig"}).

Phosphatase activity of rStp1
-----------------------------

To determine whether Stp1 of SS2 is a functional phosphatase, we expressed Stp1 in *E. coli*. The results showed that rStp1 was successfully expressed as a 41 kDa His-tagged fusion protein. Hydrolysis of pNPP was measured by assessing an increase in absorbance of pNP at 405 nm over 10 min. We observed that rStp1 hydrolyzed pNPP in the presence of Mn^2+^ ([Fig. 3](#F3){ref-type="fig"}).

Effect of *stp1* inactivation on adhesion to cultured cells
-----------------------------------------------------------

The bEnd.3 and HEp-2 cell lines were used to determine the effects of *stp1* deletion on adhesion of SS2 to host cells. [Fig. 4](#F4){ref-type="fig"} shows that the Δ*stp1* mutant exhibited better adhesion to both cell lines than that of its parent strain: 1.92 ± 0.07 vs. 0.30 ± 0.014 (*p* \< 0.01) in bEnd.3 cells and 1.92 ± 0.86 vs. 0.40 ± 0.047 (*p* \< 0.05) in HEp-2 cells.

Deletion of *stp1* led to increased resistance to killing by macrophages
------------------------------------------------------------------------

[Fig. 5](#F5){ref-type="fig"} shows that there was no marked difference in phagocytosis between Δ*stp1* mutant and its parent strain. However, the mutant was more resistant than the wild-type strain to killing by macrophages (0.79 ± 0.08 *vs*. 0.16 ± 0.037, *p* \< 0.05). By using the chemical peroxides H~2~O~2~ or paraquat in BHI broth, we observed that the Δ*stp1* mutant was more resistant than its parent strain to paraquat treatment at 5 to 10 mM (*p* \< 0.01), but not to hydrogen peroxide ([Fig. 6](#F6){ref-type="fig"}). These results suggest that deletion of *stp1* enhanced resistance to phagocytic killing, probably by increasing the resistance to reactive oxygen species (ROS).

Role of *stp1* in virulence to mice
-----------------------------------

The role of SS2-*stp1* in virulence to BALB/c mice was examined by assessing responses to inoculation of 2.44--2.47 × 10^9^ CFU of the relevant strains per mouse. Death rate was 80% for mice challenged with the wild-type strain and 20% when Δ*stp1* mutant-challenged. At day 5 post-infection, doubling the inoculum level led to 100% death (10/10) in mice receiving the wild-type strain, but only 60% (6/10) death in mice inoculated with the Δ*stp1* mutant. Compared to its parent strain, deletion of *stp1* decreased the virulence of SS2 (LD~50~: 2.7 × 10^9^ CFU for Δ*stp1* strain vs. 1.51 × 10^9^ CFU for parent strain; [Table 3](#T3){ref-type="table"}). Bacterial burdens in blood and internal organs were lower in the Δ*stp1* mutant than in its parent strain. At 48 hpi, bacterial load in organs of mice receiving the parent strain remained high, while the load at 48 hpi in mice inoculated with Δ*stp1* mutant was below the detection limit (2 log, *i.e.*, 100 CFU) of the method used ([Fig. 7](#F7){ref-type="fig"}). These findings indicate that inactivation of *stp1* reduces virulence of SS2 in mice.

Discussion
==========

In pigs and humans in Europe and Asia, SS2 is the serotype most frequently associated with disease \[[@B13]\]. A recent review indicated that there are more than 60 bacterial components that have been identified in relation to SS2 virulence, including surface and secreted factors, proteinases/enzymes, and transcriptional regulators \[[@B10]\]. Bacteria adapt to changing environments by regulating their gene expression through signal transduction systems. In SS2, SalK/SalR \[[@B20]\], IhK/Irr \[[@B19]\], and an orphan response regulator CiaRH \[[@B14]\] were reported to contribute to its virulence. Early reports have indicated that STPs have important roles in bacterial physiology, cell division, and growth by modulating phosphorylation states of their partner kinases (the serine/threonine kinases) or other substrates important in metabolism or virulence \[[@B3][@B11][@B23][@B34]\]. Herein, we present evidence that Stp1 of SS2 has phosphatase activity and is a virulence factor in a mouse model.

A *S. suis* infection starts by colonizing the nasopharyngeal tissue. Bacterial interaction with the epithelial cells in the respiratory tract is central to the initiation of infection and in further spread from the respiratory tract to the bloodstream \[[@B9]\]. Once in the bloodstream, phagocytic cells have a pivotal role against the invading pathogens. In this study, we reveal that deletion of *stp1* enhances adhesion of SS2 to both the HEp-2 and bEnd.3 cell lines, suggesting that Stp1 might suppress the adhesiveness of SS2 to host cells. This may indicate that Stp1 has a negative regulatory effect on expression of adhesins on the bacterial surface. Since the Δ*stp1* mutant exhibited increased survival in macrophages, we suspect that this might be due to an increased resistance to ROS. In the paraquat-induced superoxide radical (O~2~^−^) system, the *stp1* deletion mutant was more resistant than its parent strain. We propose that this might be related to regulation of SodA (a superoxide dismutase) by Stp1, which is capable of protecting SS2 from damage by ROS \[[@B32]\]. In *Listeria monocytogenes*, a superoxide dismutase is post-translationally controlled by phosphorylation of its STP \[[@B2]\].

Theoretically, enhanced resistance to macrophage killing as well as increased adhesion of the *stp1* deletion mutant would lead to increased virulence. However, we found that the virulence of the Δ*stp1* mutant was in fact attenuated in mice, as shown by the high LD~50~ value as well as the reduced bacterial burden in internal organs and blood. This indicates that phenotypic changes in cultured cells *in vitro* are not correlated with *in vivo* situations in this particular phosphatase Stp1. This could be due to multiplicity of target protein substrates that are regulated post-translationally by Stp1 and to changes in several functions other than adhesion and phagocytic killing. In prokaryotes, there are fewer STP than serine/threonine kinases, indicating that STPs have multiple substrates \[[@B18]\]. In *S. agalactiae*, deletion of *stk1* or double deletion of *stp-stk1* has resulted in virulence attenuation \[[@B26]\]. However, the role of *stp1* on the virulence of *S. agalactiae* remains undescribed \[[@B27]\]. The *stp* deletion mutant of *S. aureus* N315 exhibited increased resistance to antimicrobials, but it was not evaluated for its role in virulence \[[@B5]\].

Taken together, our data show for the first time that *stp1* is important in the virulence of SS2. Further studies are needed to analyze the dephosphorylation profiles of its potential substrates (including SodA) and their relationship to ensuing changes of bacterial functions; thereby resolving the discrepancy between virulence attenuation in mice and the increased adhesion and resistance to macrophage killing *in vitro* as a result of *stp1* deletion.
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![Construction of the *stp1* deletion mutant of *Streptococcus suis* type 2 and its identification by polymerase chain reaction (PCR). (A) Schematic representation of the allelic exchange of chromosomal *stp1* with vector-carried cat between pSET4s-Δ*stp1* and the chromosome of ZJ081101 by homologous recombination. (B) PCR confirmation of the mutant strain Δ*stp1*. Lane 1, primers *gadph* and *cps2J* for Δ*stp1*; Lane 2, *gadph* and *cps2J* for ZJ081101; Lanes 3, 5, and 7, primers In1/In2, Cat1/Cat2 and Cat1/Out2 for Δ*stp1*; Lanes 4, 6, and 8, primers In1/In2, Cat1/Cat2 and Cat2/Out1 for ZJ081101; M, Marker DL2000. (C) Stp1 protein is absent in the *stp1* mutant as determined by western blotting with anti-Stp1 polyclonal antibody (CPP, cytoplasmic proteins; CWP, cell-wall proteins).](jvs-18-439-g001){#F1}

![Cell morphology of *Streptococcus suis* type 2 wild-type (WT) and its isogenic Δ*stp1* mutant. Transmission electron micrographs of bacteria (A--C). Scale bars = 5 µm (A), 0.2 µm, 100 nm, 50 nm (B, from left to right), 0.2 µm, 100 nm, 100 nm (C, from left to right).](jvs-18-439-g002){#F2}

![Phosphatase activity of Stp1 of *Streptococcus suis* type 2. (A) Purification of protein Stp1. (B) Dephosphorylation of p-nitrophenyl phosphate (pNPP) with Stp1 in the Mn^2+^ buffer. (C) Kinetics of pNPP hydrolysis by Stp1 as measured at different substrate concentrations over 10 min. The K~m~ and V~max~ were determined to be 5.95 (± 1.265) mM and 1.586 (± 0.09) nmol/µg per min, respectively. OD, optical density.](jvs-18-439-g003){#F3}

![Comparison of *Streptococcus suis* type 2 wild-type (WT) and its isogenic Δ*stp1* mutant effects on adhesion to bEnd.3 and HEp-2 cell monolayers. ^\*^*p* \< 0.05, ^\*\*^*p* \< 0.01.](jvs-18-439-g004){#F4}

![Comparison of *Streptococcus suis* type 2 wild-type (WT) and its isogenic Δ*stp1* mutant effects on phagocytosis and survival in RAW 264.7 macrophage cells. ^\*\*^*p* \< 0.01. n.s., no significant difference.](jvs-18-439-g005){#F5}

![Resistance of *Streptococcus suis* type 2 wild-type (WT) and its isogenic Δ*stp1* mutant in BHI broth containing gradient levels of H~2~O~2~ or paraquat incubated at 37℃. The optical density at 620 nm was measured at hours 4 and 8. ^\*^*p* \< 0.05, ^\*\*^*p* \< 0.01. n.s., no significant difference.](jvs-18-439-g006){#F6}

![Bacterial load in organs of mice infected with *Streptococcus suis* type 2 wild-type (WT) and its isogenic Δ*stp1* mutant. As the lower limit of detection was 100 colony-forming unit (CFU), we did not suggest a null result when no single colony was present in a 10 µL spot of the organ homogenates; in such a case, we assigned an arbitrary value of 50 CFU to that sample.](jvs-18-439-g007){#F7}

###### Bacterial strains and plasmids used in this study
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###### Primers used for PCR amplification
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###### Virulence of *Streptococcus suis* type 2 wild-type (WT) and its isogenic Δ*stp1* mutant in mice
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LD~50~, lethal dose 50.
